Cyclic Nucleotide Phosphodiesterase in Human Bronchial Epithelial Cells: Characterization of Isoenzymes and Functional Effects of PDE Inhibitors

By dent G.   White S.R.   Tenor H.   Bodtke K.   Schudt C.   Leff A.R.   Magnussen H.   Rabe K.F.  

Pulmonary Pharmacology & Therapeutics, Vol. 11, Iss. 1, 1998-02 ,pp. : 47-56

Academic Press

Access to resources Recommend Favorite

The adipocyte cGMP-inhibited cyclic nucleotide phosphodiesterase (PDE3B) as a target for lipolytic and thermogenic agents for the treatment of obesity

By Snyder P.B.  

Expert Opinion on Therapeutic Targets, Vol. 3, Iss. 4, 1999-12 ,pp. : 587-599

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic potential of cyclic nucleotide phosphodiesterase inhibitors in heart failure

By Movsesian M.A.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 5, 2000-05 ,pp. : 963-973

Informa Healthcare

Access to resources Recommend Favorite

Selective Phosphodiesterase (PDE)-4 Inhibitors: A Novel Approach to Treating Memory Deficit?

By Ghavami Afshin  

Drugs in R&D, Vol. 7, Iss. 2, 2006-01 ,pp. : 63-71

Adis International

Access to resources Recommend Favorite

Cyclic Nucleotide Phosphodiesterases (PDE) and Peptide Motifs

By  

Current Pharmaceutical Design, Vol. 16, Iss. 9, 2010-03 ,pp. : 1114-1125

Bentham Science Publishers

Access to resources Recommend Favorite